Partner Ariel Soiffer and Associate Elijah Soko, along with Paul Lekas, head of global public policy at Software & Information Industry Association, recently published an article in Law360 about artificial intelligence (AI). In this article, the authors look at AI and regulatory efforts in the US and abroad, key issues when it comes to compliance, and the intersection of AI and intellectual property and AI and life sciences.
Excerpt: This article was not written by ChatGPT. Will all articles have to start with a statement like this? And will any statement like this be true?
ChatGPT uses artificial intelligence, or AI, to develop written work product. While this application of AI has grabbed the news, there are many other exciting applications of AI, including in the domain of life sciences.
In this article, we start by defining AI in the context of data, algorithms and AI systems. Next, we touch on leading regulatory efforts in the U.S. and abroad, followed by a brief overview of some key issues in compliance. After that, we assess the intersection of AI and intellectual property law. And finally, we mention some of the applications of AI in life sciences.
